Pfizer (PFE) stock prices updated...
 

Pfizer stock price, PFE

Pfizer stock chart:



Pfizer close price: 33.62

Stock price forecast:

DOWN TO -6.22%
Target: 31.53

Total forecasts: 90
Reached: 68 (75.56%)

Total Win: 42.94 (134.15%)

DaysForecastsReached%Reached points%InvestedUnreached%Total%
90916975.82%43.941.51%718.72-20.34-2.83%23.600.80%
30311238.71%6.180.63%618.15-20.63-3.34%-14.45-1.45%
1415426.67%1.470.31%364.02-5.80-1.59%-4.33-0.88%
7800.00%0.000.00%266.97-1.99-0.75%-1.99-0.75%

Showing 1-10 of 498 items.
Date of ForecastStock PriceTarget PriceForecast Reached Date
2017-02-2133.6231.510000-00-00
2017-02-2033.6231.390000-00-00
2017-02-1933.6231.570000-00-00
2017-02-1833.6231.540000-00-00
2017-02-1733.6231.820000-00-00
2017-02-1633.5131.70000-00-00
2017-02-1532.7531.860000-00-00
2017-02-1432.6132.070000-00-00
2017-02-1332.3532.230000-00-00
2017-02-1232.3532.340000-00-00

Pfizer latest news:


  • 02/17/2017 16:41:03

    Momenta Pharma shares halted as drug application hits speed bump

    Momenta Pharmaceuticals Inc. were halted in the extended session Friday after the biotech company said a supplier's compliance issue could delay approval of a higher dose of one of its multiple sclerosis drugs. Momenta shares were halted at $19 after hours. The company said a key supplier of its Glatopa multiple sclerosis drug, Pfizer Inc. , was served with a Food and Drug Administration Warning Letter, meaning something at the Pfizer facility was not in compliance with FDA code. Until the facility demonstrates compliance, Momenta said that approval for its marketing application for a 40 mg. dose of Glatopa is "unlikely" in the first quarter. Pfizer shares declined 0.4% to $33.48 after hours.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 01/31/2017 13:01:32

    Pfizer Swings to 4Q Profit After Rough Year, Hikes 2017 View

    Drugmaker Pfizer Inc. is forecasting slightly higher sales and profit this year after a difficult 2016, though reduced spending on overhead and lawsuits helped it swing to a fourth-quarter profit, following a loss a year earlier

  • 01/31/2017 06:16:00

    Pfizer 4Q Profit Misses Estimates

    Pfizer, which closed its $14 billion acquisition of Medivation in September, reported a lower-than-expected profit, hit by lower demand for products set to go off patent.

  • 12/19/2016 10:20:55

    Portola Pharma Wins on Pfizer and Bristol-Myers Loan Agreement


  • 12/12/2016 14:03:47

    Dow logs 6th consecutive record close

    The Dow Jones Industrial Average notched its sixth consecutive record close on Monday, even as the other main stock-market benchmarks finished lower. The blue-chip gauge [s:djia] gained 39.37 points, or 0.2%, to 19,796.22, led by Johnson & Johnson and Pfizer Inc. . Meanwhile, the S&P 500 index shed 2.57 points, or 0.1%, to 2,256.96 as a selloff in financials and consumer discretionary shares offset gains by telecommunications and utilities firms. The Nasdaq Composite Index slid 31.96 points, or 0.6%, to 5,412.54. Both the S&P and Nasdaq snapped six-session winning streaks. Surging oil prices helped support energy shares. U.S.-traded crude oil futures settled at their highest levels since July 2015.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 12/12/2016 10:03:23

    Pfizer raises dividend 7%; stock surges

    Shares of Pfizer Inc. surged 2.5% in midday trade Monday, after the drug giant said it was raising its quarterly dividend by 6.7%. The company said the new dividend of 32 cents a share, up from 30 cents, will be payable March 1, to shareholders of record on Feb. 3. At the current stock price of $32.51, the new annual dividend rate implies a dividend yield of 3.94%, compared with the aggregate yield for the Dow components of 2.33%, according to FactSet. "The dividend increase demonstrates our continued commitment to deliver value to our shareholders and our confidence in the business," said Chief Executive Ian Read. The stock has edged up 0.7% year to date, while the SPDR Health Care Select Sector ETF has lost 4% and the Dow has run up 14%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 12/07/2016 14:51:19

    Prologis and Western Digital Climb; Pfizer Skids

    Prologis and Western Digital trade higher on Wall Street, while Pfizer and Oxford Industries fall

  • 12/07/2016 09:23:58

    Pfizer fined $106M for 2600% price hike on epilepsy drug

    U.K. regulator imposed record fine for cost increase on anti-epilepsy medication        

  • 12/07/2016 00:20:15

    Pfizer fined record £84.2m for overcharging NHS

    Drugs giant Pfizer has been fined a record £84.2m by the regulator for overcharging the NHS.

  • More trends:

    Pharmerica CorporationPMC | PHH CorpPHH | Philip Morris International IncPM | Philippine Long Distance Telephone CompanyPHI | Phillips 66PSX+5.91% | Phillips 66 Partners LPPSXP | Phoenix CompaniesPFX | Phoenix CompaniesPNX | Phoenix New Media LimitedFENG | Physicians Realty TrustDOC |